HOME › DRUGS › PEGVISOMANT
ACTIVE SUBSTANCE / INN

PEGVISOMANT

Brand name(s): SOMAVERT, Somavert
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Acromegaly
BLA021106
ACTIVE SUBSTANCE
Pegvisomant
REGULATORS
FDA · EMA
SPONSORS / MAH
Pfizer Europe MA EEIG, PHARMACIA
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
SOMAVERTBLA021106PHARMACIAPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
SomavertPfizer Europe MA EEIGAuthorised12/11/2002Acromegaly

FULL INTELLIGENCE ON PEGVISOMANT

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →